logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10201511 B1

PDFFull Text
Date of Patent:
Feb. 12, 2019

Filed:

Jan. 05, 2013

Compositions and methods for treating metabolic disorders

Applicant:

Elcelyx Therapeutics, Inc., San Diego, CA (US);

Inventors:

Alain D. Baron, San Diego, CA (US);

Mark S. Fineman, San Diego, CA (US);

Nigel R. A. Beeley, Solana Beach, CA (US);

Assignee:

ELCELYX THERAPEUTICS, INC., San Diego, CA (US);

Attorney:

Todd A. Lorenz

Primary Examiner:

Nyeemah A Grazier

Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61P 3/10 (2006.01); C07C 279/26 (2006.01); A61K 31/155 (2006.01); C07D 317/58 (2006.01); A61K 31/357 (2006.01); C07D 307/52 (2006.01); A61K 31/341 (2006.01); A61K 9/00 (2006.01); A61K 31/19 (2006.01); A61K 31/198 (2006.01); A61K 31/7016 (2006.01); A61K 31/704 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/0053 (2013.01); A61K 9/209 (2013.01); A61K 9/2054 (2013.01); A61K 9/2846 (2013.01); A61K 9/4808 (2013.01); A61K 31/19 (2013.01); A61K 31/198 (2013.01); A61K 31/704 (2013.01); A61K 31/7016 (2013.01); A61K 45/06 (2013.01);
Abstract

Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.

Find Patent Forward Citations

Baron, Alain. (2019). Compositions and methods for treating metabolic disorders (U.S. Patent No. 10201511). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10201511

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…